|
Video: What is a Stock Split?
|
|
GSK is a biopharma company. Co. is engaged in making vaccines and specialty medicines to prevent and treat disease. Co.'s research and development focuses on the science of the immune system, human genetics and advanced technologies primarily in the following four therapeutic areas: infectious diseases, HIV, oncology and immunology/respiratory. Co.'s two reportable segments include: Commercial Operations and Total research and development. According to our GSK split history records, GSK has had 2 splits. | |
|
GSK (GSK) has 2 splits in our GSK split history database. The first split for GSK took place on July 19, 2022. GSK's second split took place on July 22, 2022.
Looking at the GSK split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into GSK shares, starting with a $10,000 purchase of GSK, presented on a split-history-adjusted basis factoring in the complete GSK split history.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/24/2014 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$55.51 |
|
End price/share: |
$40.59 |
|
Starting shares: |
180.15 |
|
Ending shares: |
302.06 |
|
Dividends reinvested/share: |
$21.13 |
|
Total return: |
22.61% |
|
Average Annual Total Return: |
2.06% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$12,262.52 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/24/2014 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$55.51 |
|
End price/share: |
$40.59 |
|
Dividends collected/share: |
$21.13 |
|
Total return: |
11.18% |
|
Average Annual Total Return: |
1.07% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$11,123.34 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
07/19/2022 | 1 for 1 | 07/22/2022 | 1 for 1 |
|
|